Patient Capital Management is a Baltimore asset manager founded in 2020 by Samantha McLemore, CFA — Bill Miller's long-time co-manager (working together since 2002, running the flagship Opportunity Equity strategy since 2014). Continuing the Miller-school contrarian tradition, it practices "time arbitrage": exploiting behavioral mispricing to concentrate in controversial growth names (tech, healthcare, Bitcoin-related) at deep discounts to intrinsic value. Its site preserves Bill Miller's complete 1995-2022 market letters, alongside ongoing quarterly letters and webinars.
This report says the market is split right now: a handful of big tech stocks (like Nvidia and the 'Magnificent Seven') are soaring, but most stocks—especially small ones—are falling. The author thinks these popular AI and tech stocks are too expensive, so future returns might disappoint. Instead, overlooked stocks like small-caps, travel, and healthcare could be bargains. For example, Expedia trades at a very low multiple, and small oil company Kosmos Energy has strong cash flow. If the economy slows, the Fed might cut rates, which could help these beaten-down stocks. Don't chase hype; look for hidden value.
Patient Capital's research report opens with a quote from Dickens' A Tale of Two Cities, exploring the current polarization in the market. The core argument is that the market has overly high expectations for high-quality compound growth stocks, AI, and tech stocks, driving up prices and potentially
This chapter opens with a quote from Dickens’ A Tale of Two Cities, depicting the current market environment of extreme polarization. The author attended a value investing conference and sensed that true value investors have become an “endangered species,” while the market fervently chases high-quality compound growth stocks and AI. The report notes that as the market hits new highs, a large number of stocks are left behind, creating a landscape where “the best of times” and “the worst of times” coexist.
The author’s central judgment is: market expectations for high-quality compound growth stocks, AI, and tech stocks have become too high, prices have been pushed up, and future returns will decline; the true value investing opportunities lie in overlooked or undervalued stocks. Counterintuitive views include:
1. Market Polarization Data
| Indicator | Data |
|---|---|
| S&P 500 Q2 Gain | +4.3% |
| Nasdaq Q2 Gain | +8.5% |
| Percentage of S&P 500 components outperforming the index | 26.4% |
| Percentage of S&P 500 stocks declining | Nearly 60% |
| Dow Jones Industrial Average Q2 Performance | -1.3% |
| Russell 2000 Q2 Performance | -3.3% |
| S&P 600 Small-Cap Q2 Performance | -3.1% |
| Magnificent 7 Contribution to YTD S&P 500 Return | 61% (S&P 500 YTD +15.3%) |
| Opportunity Equity Fund Q2 Net Return | -1.9% |
| Opportunity Equity Fund YTD Net Return | +9.6% |
2. Earnings Growth Gap and Expectations
| Group | Q1 YoY Earnings Growth | Q2 Estimate | Q4 Estimate |
|---|---|---|---|
| Mag-7 | +50% | +28% | +17% |
| S&P 500 ex-Mag-7 | -2% | +4% | +17% |
3. Economic Slowdown Signals
4. AI Bubble Analogy
This chapter continues to delve into investment strategies amid market polarization. The report notes that while the Magnificent 7 as a whole are no longer cheap, some individual stocks (e.g., Alphabet, Meta) remain within reasonable valuation ranges. The author argues that true long-term opportunities lie in overlooked small- and mid-cap stocks, healthcare, and travel sectors, where current valuations are highly attractive.
| Company/Asset | Current Price/Market Cap | Role/Key Data | View |
|---|---|---|---|
| Nvidia (NVDA) | Not provided | Core holding, fundamentals intact | Neutral to cautious, closely monitoring, not significantly overvalued |
| IAC Inc (IAC) | $46.85 / $3.96B | New/add position | Bullish, target ~$90 (double) |
| Kosmos Energy (KOS) | $5.54 / $2.6B | Added position | Bullish, target more than double, potential acquisition target |
| Everi Holdings (EVRI) | $8.40 / ~$700M | New position | Bullish, target mid-teens (double) |
| Expedia (EXPE) | $125.99 / $16.4B | Core holding | Bullish, extremely low valuation (core business 2-3x EV/EBITDA), buybacks driving growth |
| Delta Airlines (DAL) | $47.44 / $29.9B | Core holding | Bullish, business outperforms market pricing, expected to start buybacks this year |
| United Airlines (UAL) | $48.66 / $15.5B | Core holding | Bullish, business outperforms market pricing, expected to start buybacks this year |
| Norwegian Cruise Lines (NCLH) | $18.79 / $7.5B | Added after swing trading | Bullish, if 2026 EPS guidance is achieved, stock should double |
| Biogen (BIIB) | $231.82 / $32.9B | Healthcare holding | Bullish, new CEO executing well, huge opportunity in Alzheimer’s |
| Illumina (ILMN) | $104.38 / $17.4B | Healthcare holding | Bullish, leader in genomic sequencing, profitability to emerge after Grail spin-off |
| CVS (CVS) | $59.06 / $71.1B | Healthcare holding | Bullish, Medicare issues fully priced in, franchise intact |
| Royalty Pharma (RPRX) | $26.37 / $15.3B | Healthcare holding | Bullish, misunderstood by the market, strong team track record |
This section primarily defines and explains the indices, indicators, and specialized terms that recur throughout the report, providing investors with the foundational conceptual framework needed to understand subsequent analyses. These definitions cover market indices (e.g., Nasdaq Composite Index, Dow Jones Industrial Average), economic indicators (e.g., Sahm Rule Recession Indicator, Leading Economic Indicators), and specific stock portfolios (e.g., Magnificent 7, Nifty Fifty).
This section contains no core investment thesis; it is solely comprised of term definitions and compliance statements. By clearly defining the calculation methods and applicable scope of each index and indicator, the author establishes a standardized reference system for later discussions on core viewpoints such as market polarization and economic slowdown.
This section contains no analytical data, only definitional information. Key terms are defined as follows:
| Term | Definition Highlights |
|---|---|
| Nasdaq Composite Index | Market-cap weighted, covering over 3,000 stocks |
| Dow Jones Industrial Average | Price-weighted, 30 blue-chip stocks, annual sales exceeding $70 billion |
| Russell 2000 Index | Small-cap stocks, the smallest 2,000 stocks in the Russell 3000 |
| S&P 600 Small-Cap Index | Measures the U.S. small-cap stock market |
| S&P 500 Index | Market-cap weighted, 500 widely held common stocks |
| Magnificent 7 | 7 mega-cap stocks: AAPL, GOOGL, MSFT, AMZN, META, TSLA, NVDA |
| Sahm Rule Recession Indicator | Triggers a recession signal when the three-month moving average of the unemployment rate rises 0.50 percentage points above its 12-month low |
| Leading Economic Indicators (LEI) | 10 economic components whose changes precede the overall economy |
| Personal Consumption Expenditures (PCE) | A measure of U.S. personal spending on goods and services |
| Nifty Fifty | The 50 most favored large-cap NYSE stocks by institutions in the 1960s-70s |
| Capital Expenditures (CapEx) | Funds used to acquire, upgrade, and maintain physical assets |
| WTI Crude Oil | The underlying asset for crude oil futures on the NYMEX, one of the major global crude oil benchmarks |
| Purchasing Managers' Index (PMI) | An indicator of the direction of economic trends in manufacturing and services |
This section offers no direct investment implications. Its core value lies in providing investors with a unified terminology standard, ensuring that analyses in subsequent sections—such as market polarization, economic slowdown, and valuation comparisons—have a clear reference framework. Investors should familiarize themselves with these definitions to accurately understand the report's index performance comparisons (e.g., S&P 500 vs. Russell 2000), economic indicator interpretations (e.g., Sahm Rule trigger conditions), and discussions of specific stock portfolios (e.g., Mag-7 vs. remaining constituents).